PMS-METHOTREXATE INJECTION SOLUTION

Nazione: Canada

Lingua: inglese

Fonte: Health Canada

Principio attivo:

METHOTREXATE (METHOTREXATE SODIUM)

Commercializzato da:

PHARMASCIENCE INC

Codice ATC:

L04AX03

INN (Nome Internazionale):

METHOTREXATE

Dosaggio:

15MG

Forma farmaceutica:

SOLUTION

Composizione:

METHOTREXATE (METHOTREXATE SODIUM) 15MG

Via di somministrazione:

SUBCUTANEOUS

Confezione:

100

Tipo di ricetta:

Prescription

Dettagli prodotto:

Active ingredient group (AIG) number: 0107545005; AHFS:

Stato dell'autorizzazione:

APPROVED

Data dell'autorizzazione:

2023-07-18

Scheda tecnica

_pms-METHOTREXATE INJECTION page 1 of 51 _
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATIO N
PR
PMS-METHOTREXATE INJECTION
Methotrexate Injection
Solution, 10 mg / 0.2 mL (50 mg/mL) methotrexate as methotrexate
sodium, single-use
pre-filled syringe for subcutaneous injection
Solution, 12.5 mg / 0.25 mL (50 mg/mL) methotrexate as methotrexate
sodium, single-use
pre-filled syringe for subcutaneous injection
Solution, 15 mg / 0.3 mL (50 mg/mL) methotrexate as methotrexate
sodium, single-use
pre-filled syringe for subcutaneous injection
Solution, 17.5 mg / 0.35 mL (50 mg/mL) methotrexate as methotrexate
sodium, single-use
pre-filled syringe for subcutaneous injection
Solution, 20 mg / 0.4 mL (50 mg/mL) methotrexate as methotrexate
sodium, single-use
pre-filled syringe for subcutaneous injection
Solution, 22.5 mg / 0.45 mL (50 mg/mL) methotrexate as methotrexate
sodium, single-use
pre-filled syringe for subcutaneous injection
Solution, 25 mg / 0.5 mL (50 mg/mL) methotrexate as methotrexate
sodium, single-use
pre-filled syringe for subcutaneous injection
House Standard
Immunosuppressant
PHARMASCIENCE INC.
6111 Royalmount Ave., Suite 100
Montréal, Quebec, H4P 2T4
Submission Control Number: 268544
Date of Initial Authorization:
July 14, 2023
_pms-METHOTREXATE INJECTION page 2 of 51 _
RECENT MAJOR LABEL CHANGES
_None at the time of authorization _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.................................................................................................
4
1
INDICATIONS
.............................................................................................................................................
4
1.1
PEDIATRICS
.....................................................................................................................................
4
1.2
GERIATRICS
.....................................................................................................................................
4
2
CONTRAINDICATIONS
......................................